DRF-1042 T15168
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 displays perfect anticancer activity against a panel of human cancer cell lines including multi-drug resistance (MDR) phenotype.
CAS nr:
200619-13-2
Purity:
98%
Molecular Weight:
408,4
SMILES:
O=C1[C@](CC)(C2=C(C(N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)=O)CO1)O
Formula:
C22H20N2O6
Pathway:
Others
Target:
Others
